NDC 43742-0944 – Oratox

Fucus Vesiculosus 3 [hp_X]/mL; Sus Scrofa Lymph 8 [hp_X]/mL; Sus Scrofa Bone Marrow 8 [hp_X]/mL; Sus Scrofa Thymus 8 [hp_X]/mL; Thyroid 8 [hp_X]/mL; Calcium… · Liquid · Oral

Human Otc Drug

Product NDC43742-0944

Product details

Brand name
Oratox
Generic name
Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum
Labeler
Deseret Biologicals, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
December 27, 2016
Listing expires
December 31, 2026
Pharmacologic class
Amide Local Anesthetic; Antiarrhythmic; Blood Coagulation Factor; Copper-containing Intrauterine Device; Phosphate Binder; Standardized Chemical Allergen; Standardized Chemical Allergen; Standardized Chemical Allergen; Standardized Chemical Allergen

Active ingredients

Uses, dosage, side effects and warnings for Oratox →

Package NDC codes (1)

Package NDCDescriptionSince
43742-0944-130 mL in 1 BOTTLE, DROPPER (43742-0944-1)Dec 27, 2016